Search

Your search keyword '"Avsar, Murat"' showing total 476 results
Start Over Author "Avsar, Murat"
476 results on '"Avsar, Murat"'

1. Matched comparison of decellularized homografts and bovine jugular vein conduits for pulmonary valve replacement in congenital heart disease

Author

Bobylev, Dmitry, Horke, Alexander, Avsar, Murat, Cvitkovic, Tomislav, Boethig, Dietmar, Hazekamp, Mark, Meyns, Bart, Rega, Filip, Dave, Hitendu, Schmiady, Martin, Ciubotaru, Anatol, Cheptanaru, Eduard, Vida, Vladimiro, Padalino, Massimo, Tsang, Victor, Jashari, Ramadan, Laufer, Günther, Andreas, Martin, Andreeva, Alexandra, Tudorache, Igor, Cebotari, Serghei, Haverich, Axel, and Sarikouch, Samir

Published
2024
Full Text
View/download PDF

3. Lung transplantation despite preformed donor-specific antihuman leukocyte antigen antibodies: a 9-year single-center experience

Author

Heise, Emma L., Chichelnitskiy, Evgeny, Greer, Mark, Franz, Maximilian, Aburahma, Khalil, Iablonskii, Pavel, de Manna, Nunzio D., Christoph, Stella, Verboom, Murielle, Hallensleben, Michael, Boethig, Dietmar, Avsar, Murat, Welte, Tobias, Schwerk, Nicolaus, Sommer, Wiebke, Haverich, Axel, Warnecke, Gregor, Kuehn, Christian, Falk, Christine, Salman, Jawad, and Ius, Fabio

Published
2023
Full Text
View/download PDF

4. Heart transplantation across preformed donor-specific antibody barriers using a perioperative desensitization protocol

Author

Sommer, Wiebke, Avsar, Murat, Aburahma, Khalil, Salman, Jawad, Kaufeld, Klaus Tim, Rojas, Sebastian V., Meyer, Anna L., Chichelnitskiy, Evgeny, Süsal, Caner, Kreusser, Michael M., Verboom, Murielle, Hallensleben, Michael, Bara, Christoph, Blasczyk, Rainer, Falk, Christine, Karck, Matthias, Haverich, Axel, Ius, Fabio, and Warnecke, Gregor

Published
2022
Full Text
View/download PDF

5. Extracorporeal membrane oxygenation as a bridge to transplant in severe pulmonary hypertension.

Author

Kruszona, Sophie, Aburahma, Khalil, Wand, Philipp, Manna, Nunzio D de, Avsar, Murat, Bobylev, Dmitry, Müller, Carsten, Carlens, Julia, Weymann, Alexander, Schwerk, Nicolaus, Welte, Tobias, Liu, Bin, Ruhparwar, Arjang, Kuehn, Christian, Salman, Jawad, Greer, Mark, and Ius, Fabio

Subjects
BRAIN natriuretic factor, LUNG transplantation, DISEASE risk factors, INTENSIVE care units, PULMONARY hypertension
Abstract

OBJECTIVES Severe pulmonary hypertension (PH) is the leading indication for a lung transplant in younger patients. Despite the availability of validated risk scores, their influence on lung allocation has been negligible, with continued reliance on decompensation and bridging with extracorporeal membrane oxygenation (ECMO). This single-centre, retrospective study assessed outcome of ECMO bridging in lung transplant for PH and evaluated short-term predictability of ECMO bridging. METHODS Patients with PH listed for a lung transplant between January 2010 and March 2023 were included. Peri- and postoperative courses were compared dependent upon ECMO bridging status. Bridging risk analysis within 90 days of re-evaluation included patients not requiring ECMO at listing, with listing parameters evaluated using a univariate Cox proportional hazard regression. RESULTS A total of 114/123 patients listed underwent lung transplant. Twenty-eight required ECMO bridging. No differences in primary graft dysfunction grade 3 at 72 h (30 vs 20%; P  = 0.28) or graft survival (1 year: 82 vs 88%; 5 years: 54 vs 59%; P  = 0.84) were evident. ECMO bridging resulted in longer intensive care unit stays post-transplant (P  = 0.002) and higher rates of both re-thoracotomy (P  = 0.049) and vascular complications (P  = 0.031). Factors increasing 90-day ECMO risk included N-terminal pro-B-type natriuretic peptide (P  < 0.001), 6-min walk distance (P  = 0.03) and O2 requirement at rest (P  = 0.006). CONCLUSIONS Lung transplant survival outcomes are not affected by ECMO bridging in patients with severe PH. It does, however, expose patients to additional risk, and efforts such as easy-to-measure parameters to pre-emptively identify patients requiring bridging to assist with effective allocation should be encouraged. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Indications and outcome after lung transplantation in children under 12 years of age: A 16-year single center experience

Author

Iablonskii, Pavel, Carlens, Julia, Mueller, Carsten, Aburahma, Khalil, Niehaus, Adelheid, Boethig, Dietmar, Franz, Maximilian, Floethmann, Katharina, Sommer, Wiebke, Optenhoefel, Joerg, Tudorache, Igor, Greer, Mark, Koeditz, Harald, Jack, Thomas, Hansmann, Georg, Kuehn, Christian, Horke, Alexander, Hansen, Gesine, Haverich, Axel, Warnecke, Gregor, Avsar, Murat, Salman, Jawad, Bobylev, Dmitry, Ius, Fabio, and Schwerk, Nicolaus

Published
2022
Full Text
View/download PDF

7. Delayed non-myeloablative irradiation to induce long-term allograft acceptance in a large animal lung transplantation model

Author

Hacker, Karolin S., Jansson, Katharina, Pichler, Jeanette, Salman, Jawad, Avsar, Murat, Siemeni, Thierry, Knöfel, Ann-Kathrin, Höffler, Klaus, Gottlieb, Jens, Frühauf, Jörg, Werner, Martin, Poyanmehr, Reza, Jonigk, Danny, Balzer, Michael S., Hewicker-Trautwein, Marion, Haverich, Axel, Sommer, Wiebke, and Warnecke, Gregor

Published
2021
Full Text
View/download PDF

9. Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation

Author

Ius, Fabio, Aburahma, Khalil, Boethig, Dietmar, Salman, Jawad, Sommer, Wiebke, Draeger, Helge, Poyanmehr, Reza, Avsar, Murat, Siemeni, Thierry, Bobylev, Dmitry, Optenhoefel, Joerg, Wiesner, Olaf, Greer, Mark, Schwerk, Nicolaus, Hoeper, Marius M., Welte, Tobias, Haverich, Axel, Kuehn, Christian, Warnecke, Gregor, Gottlieb, Jens, and Tudorache, Igor

Published
2020
Full Text
View/download PDF

10. 5-year results from a prospective, single-arm european trial on decellularized allografts for aortic valve replacement—the ARISE study and ARISE registry data

Author

Horke, Alexander, primary, Tudorache, Igor, additional, Laufer, Günther, additional, Andreas, Martin, additional, Pomar, Jose Luis, additional, Pereda, Daniel, additional, Quintana, Eduard, additional, Sitges, Marta, additional, Meyns, Bart, additional, Rega, Filip, additional, Hazekamp, Mark, additional, Cesnjevar, Robert, additional, Schmiady, Martin Oliver, additional, Pepper, John, additional, Rosendahl, Ulrich, additional, Lichtenberg, Artur, additional, Stadnik, Dmytro, additional, Jashari, Ramadan, additional, Boethig, Dietmar, additional, Bobylev, Dmitry, additional, Avsar, Murat, additional, Ruhparwar, Arjang, additional, Haverich, Axel, additional, Cebotari, Serghei, additional, and Sarikouch, Samir, additional

Published
2024
Full Text
View/download PDF

11. Paediatric aortic valve replacement using decellularized allografts: a multi-Centre update following 143 implantations and 5-year mean follow-up

Author

Horke, Alexander, primary, Bobylev, Dmitry, additional, Avsar, Murat, additional, Cvitkovic, Tomislav, additional, Meyns, Bart, additional, Rega, Filip, additional, Hazekamp, Mark, additional, Cesnjevar, Robert, additional, Schmiady, Martin, additional, Staebler, Brigitte, additional, Dewald, Oliver, additional, Ciubotaru, Anatol, additional, Michel-Behnke, Ina, additional, Zimpfer, Daniel, additional, Jashari, Ramadan, additional, Boethig, Dietmar, additional, Cebotari, Serghei, additional, Beerbaum, Philipp, additional, Tudorache, Igor, additional, and Sarikouch, Samir, additional

Published
2024
Full Text
View/download PDF

16. Simultaneous Aortic and Pulmonary Valve Replacement in Repaired Congenital Heart Disease.

Author

Bobylev, Dmitry, Hysko, Klea, Avsar, Murat, Cvitkovic, Tomislav, Petena, Elena, Sarikouch, Samir, Bleck, Mechthild Westhoff, Hansmann, Georg, Haverich, Axel, and Horke, Alexander

Subjects
AORTIC valve transplantation, CONGENITAL heart disease, PULMONARY valve, CARDIAC patients, CARDIOPULMONARY bypass
Abstract

Objectives Patients with congenital heart disease frequently require surgical or percutaneous interventional valve replacement after initial congenital heart defect (CHD) repair. In some of these patients, simultaneous replacement of both semilunar valves is necessary, resulting in increased procedural complexity, morbidity, and mortality. In this study, we analyze the outcomes of simultaneous aortic and pulmonary valve replacements following multiple surgical interventions for CHD. Methods This was a retrospective study of 24 patients who after initial repair of CHD underwent single-stage aortic and pulmonary valve replacement at our institution between 2003 and 2021. Results The mean age of the patients was 28 ± 13 years; the mean time since the last surgery was 15 ± 11 years. Decellularized valved homografts (DVHs) were used in nine patients, and mechanical valves were implanted in seven others. In eight patients, DVHs, biological, and mechanical valves were implanted in various combinations. The mean cardiopulmonary bypass time was 303 ± 104 minutes, and aortic cross-clamp time was 152 ± 73 minutes. Two patients died at 12 and 16 days postoperatively. At a maximum follow-up time of 17 years (mean 7 ± 5 years), 95% of the surviving patients were categorized as New York Heart Association heart failure class I. Conclusion Single-stage aortic and pulmonary valve replacement after initial repair of CHD remains challenging with substantial perioperative mortality (8.3%). Nevertheless, long-term survival and clinical status at the latest follow-up were excellent. The valve type had no relevant impact on the postoperative course. The selection of the valves for implantation should take into account operation-specific factors—in particular reoperability—as well as the patients' wishes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study

Author

Warnecke, Gregor, Van Raemdonck, Dirk, Smith, Michael A, Massard, Gilbert, Kukreja, Jasleen, Rea, Federico, Loor, Gabriel, De Robertis, Fabio, Nagendran, Jayan, Dhital, Kumud K, Moradiellos Díez, Francisco Javier, Knosalla, Christoph, Bermudez, Christian A, Tsui, Steven, McCurry, Kenneth, Wang, I-Wen, Deuse, Tobias, Lesèche, Guy, Thomas, Pascal, Tudorache, Igor, Kühn, Christian, Avsar, Murat, Wiegmann, Bettina, Sommer, Wiebke, Neyrinck, Arne, Schiavon, Marco, Calabrese, Fiorella, Santelmo, Nichola, Olland, Anne, Falcoz, Pierre-Emanuel, Simon, Andre R, Varela, Andres, Madsen, Joren C, Hertz, Marshall, Haverich, Axel, and Ardehali, Abbas

Published
2018
Full Text
View/download PDF

19. Single Lung Transplantation in a Highly Selected Patient With End‐Stage Chronic Thromboembolic Pulmonary Hypertension.

Author

de Manna, Nunzio Davide, Aburahma, Khalil, Kruszona, Sophie, Wand, Philipp, Avsar, Murat, Derlin, Thorsten, Olsson, Karen M., Ruhparwar, Arjang, Kühn, Christian, Hoeper, Marius M., Greer, Mark, Salman, Jawad, and Ius, Fabio

Subjects
SINGLE-photon emission computed tomography, LEFT ventricular dysfunction, RIGHT ventricular dysfunction, TRICUSPID valve insufficiency, VASCULAR resistance, EXTRACORPOREAL membrane oxygenation, BODY surface area
Published
2024
Full Text
View/download PDF

23. Paediatric aortic valve replacement using decellularized allografts: a multicentre update following 143 implantations and five-year mean follow-up.

Author

Horke, Alexander, Bobylev, Dmitry, Avsar, Murat, Cvitkovic, Tomislav, Meyns, Bart, Rega, Filip, Hazekamp, Mark, Cesnjevar, Robert, Schmiady, Martin, Staebler, Brigitte, Dewald, Oliver, Ciubotaru, Anatol, Michel-Behnke, Ina, Zimpfer, Daniel, Jashari, Ramadan, Boethig, Dietmar, Cebotari, Serghei, Beerbaum, Philipp, Tudorache, Igor, and Sarikouch, Samir

Subjects
AORTIC valve transplantation, PEDIATRICS, CHILD patients, CARDIOPULMONARY bypass, AORTIC valve diseases, HOMOGRAFTS
Abstract

Open in new tab Download slide OBJECTIVES Decellularized aortic homografts (DAH) were introduced in 2008 as a further option for paediatric aortic valve replacement (AVR). METHODS Prospective, multicentre follow-up of all paediatric patients receiving DAH for AVR in 8 European centres. RESULTS A total of 143 DAH were implanted between February 2008 and February 2023 in 137 children (106 male, 74%) with a median age of 10.8 years (interquartile range 6.6–14.6). Eighty-four (59%) had undergone previous cardiac operations and 24 (17%) had undergone previous AVR. The median implanted DAH diameter was 21 mm (interquartile range 19–23). The median operation duration was 348 min (227–439) with a median cardiopulmonary bypass time of 212 min (171–257) and a median cross-clamp time of 135 min (113–164). After a median follow-up of 5.3 years (3.3–7.2, max. 15.2 years), the primary efficacy end-points peak gradient (median 14 mmHg, 9–28) and regurgitation (median 0.5, interquartile range 0–1, grade 0–3) showed good results but an increase over time. Freedom from death/explantation/endocarditis/bleeding/thromboembolism at 5 years were 97.8 ± 1.2/88.7 ± 3.3/99.1 ± 0.9/100 and 99.2 ± 0.8%, respectively. Freedom from death/explantation/endocarditis/bleeding/thromboembolism at 10 years were 96.3 ± 1.9/67.1 ± 8.0/93.6 ± 3.9/98.6 ± 1.4 and 86.9 ± 11.6%, respectively. In total, 21 DAH were explanted. Seven were replaced by a mechanical AVR, 1 Ross operation was performed and a re-do DAH was implanted in 13 patients with no redo mortality. The calculated expected adverse events were lower for DAH compared to cryopreserved homograft patients (mean age 8.4 years), and in the same range as for Ross patients (9.2 years) and mechanical AVR (13.0 years). CONCLUSIONS This large-scale prospective analysis demonstrates excellent mid-term survival using DAH with adverse event rates comparable to paediatric Ross procedures. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Heart Transplantation in High-Risk Recipients Employing Donor Marginal Grafts Preserved With Ex-Vivo Perfusion

Author

Sponga, Sandro, primary, Vendramin, Igor, additional, Salman, Jawad, additional, Ferrara, Veronica, additional, De Manna, Nunzio Davide, additional, Lechiancole, Andrea, additional, Warnecke, Gregor, additional, Dralov, Andriy, additional, Haverich, Axel, additional, Ius, Fabio, additional, Bortolotti, Uberto, additional, Livi, Ugolino, additional, and Avsar, Murat, additional

Published
2023
Full Text
View/download PDF

26. Bilateral lung transplantation for pediatric pulmonary arterial hypertension: perioperative management and one-year follow-up

Author

Jack, Thomas, primary, Carlens, Julia, additional, Diekmann, Franziska, additional, Hasan, Hosan, additional, Chouvarine, Philippe, additional, Schwerk, Nicolaus, additional, Müller, Carsten, additional, Wieland, Ivonne, additional, Tudorache, Igor, additional, Warnecke, Gregor, additional, Avsar, Murat, additional, Horke, Alexander, additional, Ius, Fabio, additional, Bobylev, Dmitry, additional, and Hansmann, Georg, additional

Published
2023
Full Text
View/download PDF

28. Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results

Author

Ius, Fabio, Sommer, Wiebke, Tudorache, Igor, Avsar, Murat, Siemeni, Thierry, Salman, Jawad, Molitoris, Ulrich, Gras, Clemens, Juettner, Bjoern, Puntigam, Jakob, Optenhoefel, Joerg, Greer, Mark, Schwerk, Nicolaus, Gottlieb, Jens, Welte, Tobias, Hoeper, Marius M., Haverich, Axel, Kuehn, Christian, and Warnecke, Gregor

Published
2016
Full Text
View/download PDF

30. Matched comparison of decellularized homografts and bovine jugular vein conduits for pulmonary valve replacement in congenital heart disease

Author

Bobylev, Dmitry, Horke, Alexander, Avsar, Murat, Cvitkovic, Tomislav, Boethig, Dietmar, Hazekamp, Mark, Meyns, Bart, Rega, Filip, Dave, Hitendu, Schmiady, Martin, Ciubotaru, Anatol, Cheptanaru, Eduard, Vida, Vladimiro, Padalino, Massimo, Tsang, Victor, Jashari, Ramadan, Laufer, Günther, Andreas, Martin, Andreeva, Alexandra, Tudorache, Igor, Cebotari, Serghei, Haverich, Axel, Sarikouch, Samir; https://orcid.org/0000-0001-7277-7597, Bobylev, Dmitry, Horke, Alexander, Avsar, Murat, Cvitkovic, Tomislav, Boethig, Dietmar, Hazekamp, Mark, Meyns, Bart, Rega, Filip, Dave, Hitendu, Schmiady, Martin, Ciubotaru, Anatol, Cheptanaru, Eduard, Vida, Vladimiro, Padalino, Massimo, Tsang, Victor, Jashari, Ramadan, Laufer, Günther, Andreas, Martin, Andreeva, Alexandra, Tudorache, Igor, Cebotari, Serghei, Haverich, Axel, and Sarikouch, Samir; https://orcid.org/0000-0001-7277-7597

Abstract

For decades, bovine jugular vein conduits (BJV) and classic cryopreserved homografts have been the two most widely used options for pulmonary valve replacement (PVR) in congenital heart disease. More recently, decellularized pulmonary homografts (DPH) have provided an alternative avenue for PVR. Matched comparison of patients who received DPH for PVR with patients who received bovine jugular vein conduits (BJV) considering patient age group, type of heart defect, and previous procedures. 319 DPH patients were matched to 319 BJV patients; the mean age of BJV patients was 15.3 (SD 9.5) years versus 19.1 (12.4) years in DPH patients (p = 0.001). The mean conduit diameter was 24.5 (3.5) mm for DPH and 20.3 (2.5) mm for BJV (p < 0.001). There was no difference in survival rates between the two groups after 10 years (97.0 vs. 98.1%, p = 0.45). The rate of freedom from endocarditis was significantly lower for BJV patients (87.1 vs. 96.5%, p = 0.006). Freedom from explantation was significantly lower for BJV at 10 years (81.7 vs. 95.5%, p = 0.001) as well as freedom from any significant degeneration at 10 years (39.6 vs. 65.4%, p < 0.001). 140 Patients, matched for age, heart defect type, prior procedures, and conduit sizes of 20–22 mm (± 2 mm), were compared separately; mean age BJV 8.7 (4.9) and DPH 9.5 (7.3) years (p = n.s.). DPH showed 20% higher freedom from explantation and degeneration in this subgroup (p = 0.232). Decellularized pulmonary homografts exhibit superior 10-year results to bovine jugular vein conduits in PVR.

Published
2023

31. Bilateral lung transplantation for pediatric pulmonary arterial hypertension: perioperative management and one-year follow-up

Author

Jack, Thomas, Carlens, Julia; https://orcid.org/0000-0001-8578-864X, Diekmann, Franziska, Hasan, Hosan, Chouvarine, Philippe, Schwerk, Nicolaus, Müller, Carsten, Wieland, Ivonne, Tudorache, Igor, Warnecke, Gregor, Avsar, Murat, Horke, Alexander, Ius, Fabio, Bobylev, Dmitry, Hansmann, Georg, Jack, Thomas, Carlens, Julia; https://orcid.org/0000-0001-8578-864X, Diekmann, Franziska, Hasan, Hosan, Chouvarine, Philippe, Schwerk, Nicolaus, Müller, Carsten, Wieland, Ivonne, Tudorache, Igor, Warnecke, Gregor, Avsar, Murat, Horke, Alexander, Ius, Fabio, Bobylev, Dmitry, and Hansmann, Georg

Abstract

Background: Bilateral lung transplantation (LuTx) remains the only established treatment for children with end-stage pulmonary arterial hypertension (PAH). Although PAH is the second most common indication for LuTx, little is known about optimal perioperative management and midterm clinical outcomes. Methods: Prospective observational study on consecutive children with PAH who underwent LuTx with scheduled postoperative VA-ECMO support at Hannover Medical School from December 2013 to June 2020. Results: Twelve patients with PAH underwent LuTx (mean age 11.9 years; age range 1.9–17.8). Underlying diagnoses included idiopathic (n = 4) or heritable PAH (n = 4), PAH associated with congenital heart disease (n = 2), pulmonary veno-occlusive disease (n = 1), and pulmonary capillary hemangiomatosis (n = 1). The mean waiting time was 58.5 days (range 1–220d). Three patients were bridged to LuTx on VA-ECMO. Intraoperative VA-ECMO/cardiopulmonary bypass was applied and VA-ECMO was continued postoperatively in all patients (mean ECMO-duration 185 h; range 73–363 h; early extubation). The median postoperative ventilation time was 28 h (range 17–145 h). Echocardiographic conventional and strain analysis showed that 12 months after LuTx, all patients had normal biventricular systolic function. All PAH patients are alive 2 years after LuTx (median follow-up 53 months, range 26–104 months). Conclusion: LuTx in children with end-stage PAH resulted in excellent midterm outcomes (100% survival 2 years post-LuTx). Postoperative VA-ECMO facilitates early extubation with rapid gain of allograft function and sustained biventricular reverse-remodeling and systolic function after RV pressure unloading and LV volume loading.

Published
2023

32. Impact of Total Ischemic Time and Disease Severity Class on Graft Function after Bilateral Lung Transplantation

Author

Aburahma, Khalil, primary, de Manna, Nunzio D, additional, Boethig, Dietmar, additional, Franz, Maximilian, additional, Iablonskii, Pavel, additional, Heise, Emma L, additional, Bobylev, Dmitry, additional, Avsar, Murat, additional, Greer, Mark, additional, Schwerk, Nicolaus, additional, Sommer, Wiebke, additional, Welte, Tobias, additional, Haverich, Axel, additional, Warnecke, Gregor, additional, Kuehn, Christian, additional, Salman, Jawad, additional, and Ius, Fabio, additional

Published
2023
Full Text
View/download PDF

33. Lungs From Donors ≥70 Years of Age for Transplantation—Do Long-Term Outcomes Justify Their Use?

Author

Sommer, Wiebke, primary, Franz, Maximilian, additional, Aburahma, Khalil, additional, Saipbaev, Akylbek, additional, Flöthmann, Katharina, additional, Yablonski, Pavel, additional, Avsar, Murat, additional, Tudorache, Igor, additional, Greer, Mark, additional, Haverich, Axel, additional, Welte, Tobias, additional, Kuehn, Christian, additional, Salman, Jawad, additional, Warnecke, Gregor, additional, and Ius, Fabio, additional

Published
2023
Full Text
View/download PDF

34. Matched comparison of decellularized homografts and bovine jugular vein conduits for pulmonary valve replacement in congenital heart disease

Author

Bobylev, Dmitry, primary, Horke, Alexander, additional, Avsar, Murat, additional, Cvitkovic, Tomislav, additional, Boethig, Dietmar, additional, Hazekamp, Mark, additional, Meyns, Bart, additional, Rega, Filip, additional, Dave, Hitendu, additional, Schmiady, Martin, additional, Ciubotaru, Anatol, additional, Cheptanaru, Eduard, additional, Vida, Vladimiro, additional, Padalino, Massimo, additional, Tsang, Victor, additional, Jashari, Ramadan, additional, Laufer, Günther, additional, Andreas, Martin, additional, Andreeva, Alexandra, additional, Tudorache, Igor, additional, Cebotari, Serghei, additional, Haverich, Axel, additional, and Sarikouch, Samir, additional

Published
2023
Full Text
View/download PDF

40. Does donor–recipient age mismatch have an influence on outcome after lung transplantation? A single-centre experience

Author

Franz, Maximilian, primary, Aburahma, Khalil, additional, Avsar, Murat, additional, Boethig, Dietmar, additional, Greer, Mark, additional, Alhadidi, Hani, additional, Sommer, Wiebke, additional, Tudorache, Igor, additional, Warnecke, Gregor, additional, Haverich, Axel, additional, Ius, Fabio, additional, and Salman, Jawad, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results